We have a great episode for you today featuring Medicinal Genomics Chief Scientific Officer Kevin McKernan. Kevin is a legend in the genomic sequencing space going back to his days working on the human genome project. He has applied his experience and knowledge to trying to better understand the cannabis genome, which as he mentions in the episode is one …
Medicinal Genomics invites you to listen to our new CannMed Coffee Talk Podcast. Each episode we talk with the leading minds in cannabis science, medicine, cultivation, and safety testing, discussing topics from the bench to the bedside. Don’t miss this opportunity to get a sneak-peek into the 4 FOCUS AREAS that will be covered at CannMed 2020 in Pasadena, CA on September 20-22, 2020.
It’s happening! 214 days until #CannMed2020! Join Medicinal Genomics and 60+ presenters in Pasadena, CA on September 20-22. Our 24,840 square foot exhibit hall will be filled with 50+ industry leading sponsors, exhibitors, and advocacy groups showcasing the greatest minds in cannabis science, medicine, cultivation, and safety. CannMed was born to promote understanding of cannabis’ complex science and its medical benefits …
Many parts of the world have used cannabis as a medicine for thousands of years, but we have only truly begun to understand the mechanisms by which cannabis provides relief in the last century. Much of the evidence currently available is anecdotal or preclinical, which is insufficient for demonstrating true efficacy in humans. Furthermore, while we now have a decent …
As cannabis gains wider acceptance in the mainstream there is an ever growing need to ensure that consumers are receiving quality product with known potency that is free of contaminants. At present there are 33 states in the US that have legalized cannabis for medicinal use and 11 for recreational use. In this nascent industry, many aspects of how to …
They say that an ounce of prevention is worth a pound of cure. While cannabis cultivation may seem simple to the layman it is riddled with potential bumps in the road that could be extremely costly. Plant pathogens are just one of these bumps and they can lead to inferior product and can also greatly reduce yield and/or total crop …
Recent events surrounding a cannabis genomics company in Oregon have sparked outrage amongst the cannabis community. This particular organization offered sequencing services claiming it would serve as a mechanism for demonstrating prior art to combat future patents. Instead, those services were used to stock a breeding program that would directly compete with the very same cultivators who purchased their services. …
We had a chance to catch up with Meredith Burak, Director of Global Relations for Asana Bio Group, who will lead a Women’s Health panel at CannMed 2018, comprised of experts who are advancing science and products to benefit women’s health. In the video below, Burak shares some of the information she has found while studying how cannabis can help …
Our latest CannMed 2018 speaker interview is with Rob Viglione from Horizen who will be speaking as part of our Cryptocurrency Track at CannMed 2018. Cryptocurrencies and blockchains can radically disrupt many aspects of the cannabis market. Cryptocurrencies are now funding cannabis research projects, Cannabis scientific conferences, and ICO financing. The CannMed Crypto track will touch on ICO financing in the cannabis space, cryptocurrencies …
In our latest CannMed 2018 speaker interview, David Meiri provides some amazing insight into how he and his team are working to understand the specific cannabis compounds that can be used to kill cancer cells. What they have found so far is fascinating. By testing different cannabis extracts on cancer cells with specific genetic mutations, they can identify which cannabis …
